Current Myriad Genetics forecasts and price targets in August 2026
Ø Analyst Price Targets
7.85 USD
+174.62 %
Median
7.14 USD
+149.65 %
Max
18.90 USD
Min
3.54 USD
Last Price
2.86 USD
Buy
3
Hold
9
Sell
6
The average target price for Myriad Genetics is 7.85 USD. (+174.62 % above the current price)
The median price target of Myriad Genetics is 7.14 USD.
Stock analysts from many renowned investment banks are closely examining the Myriad Genetics stock. They conclude their professional Myriad Genetics stock analyses with a clear recommendation for the Myriad Genetics stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-03-01 | 3 | 9 | 6 | — |
| 2026-02-01 | 3 | 9 | 6 | 7.85 USD |
| 2026-02-01 | 3 | 9 | 6 | 7.85 USD |
| 2026-01-01 | 3 | 9 | 6 | 7.85 USD |
| 2025-12-01 | 3 | 10 | 6 | 8.22 USD |
| 2025-12-01 | 3 | 10 | 6 | 8.22 USD |
Myriad Genetics Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Myriad Genetics in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 863.00 M USD | 5.00 M USD | 0.05 USD |
| 2027e | 915.00 M USD | 13.00 M USD | 0.14 USD |
| 2028e | 970.00 M USD | 25.00 M USD | 0.27 USD |